Heparan sulfate regulation of progenitor cell fate

Journal of Cellular Biochemistry

Volumn 99, Issue 4, 2006, Pages 1040-1051

  Cool, Simon M ^a,b   Nurcombe, Victor ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Differentiation; Extracellular matrix; Growth factors; Lineage; Proliferation; Stem cell

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARAN SULFATE; SUGAR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CONTROL SYSTEM; EXTRACELLULAR MATRIX; MOLECULAR BIOLOGY; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROBABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CELL LINEAGE; GROWTH SUBSTANCES; HEPARITIN SULFATE; HUMANS; PHENOTYPE; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 33750551320     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20936     Document Type: Article

References (110)

1. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA. 2000. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227:271-278.
2. Aszodi A, Bateman JF, Gustafsson E, Boot-Handford R, Fassler R. 2000. Mammalian skeletogenesis and extracellular matrix: What can we learn from knockout mice? Cell Struct Funct 25:73-84.
3. Bandtlow CE, Zimmermann DR. 2000. Proteoglycans in the developing brain: New conceptual insights for old proteins. Physiol Rev 80:1267-1290.
4. Bellaiche Y, The I, Perrimon N. 1998. Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature 394:85-88.
5. Bennett KL, Bradshaw J, Youngman T, Rodgers J, Greenfield B, Aruffo A, Linsley PS. 1997. Deleted in colorectal carcinoma (DCC) binds heparin via its fifth fibronectin type III domain. J Biol Chem 272:26940-26946.
6. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ. 1992. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8:365-393.
7. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729-777.
8. Bingley JA, Hayward IP, Campbell JH, Campbell GR. 1998. Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo. J Vasc Surg 28:308-318.
9. Blau HM, Brazelton TR, Weimann JM. 2001. The evolving concept of a stem cell: Entity or function? Cell 105:829-841.
10. Boilly B, Vercoutter-Edouarta AS, Hondermarcka H, Nurcombeb V, Le Bourhisa X. 2000. FGF signals for cell proliferation and migration through different pathways [In Process Citation]. Cytokine Growth Factor Rev 11:295-302.
11. Brazelton TR, Rossi FM, Keshet GI, Blau HM. 2000. From marrow to brain: Expression of neuronal phenotypes in adult mice. Science 290:1775-1779.
12. Brickman YG, Ford MD, Small DH, Bartlett PF, Nurcombe V. 1995. Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells. J Biol Chem 270:24941-24948.
13. Brickman YG, Ford MD, Gallagher JT, Nurcombe V, Bartlett PF, Turnbull JE. 1998. Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 273:4350-4359.
14. Burgess WH, Shaheen AM, Hampton B, Donohue PJ, Winkles JA. 1991. Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis. J Cell Biochem 45:131-138.
15. Campbell JH, Rennick RE, Kalevitch SG, Campbell GR. 1992. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype. Exp Cell Res 200:156-167.
16. Carey DJ. 1997. Syndecans: Multifunctional cell-surface co-receptors. Biochem J 327 (Pt 1):1-16.
17. Carpenter MK, Cui X, Hu ZY, Jackson J, Sherman S, Seiger A, Wahlberg LU. 1999. In vitro expansion of a multipotent population of human neural progenitor cells. Exp Neurol 158:265-278.
18. Chang Z, Meyer K, Rapraeger AC, Friedl A. 2000. Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. Faseb J 14:137-144.
19. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE. 1998. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142:295-305.
20. Chipperfield H, Bedi KS, Cool SM, Nurcombe V. 2002. Heparan sulfates isolated from adult neural progenitor cells can direct phenotypic maturation. Int J Dev Biol 46:661-670.
21. Cohen J, Burne JF, Winter J, Bartlett P. 1986. Retinal ganglion cells lose response to laminin with maturation. Nature 322:465-467.
22. Cole GJ, Akeson R. 1989. Identification of a heparin binding domain of the neural cell adhesion molecule N-CAM using synthetic peptides. Neuron 2:1157-1165.
23. Colin S, Jeanny J-C, Mascarelli F, Vienet R, Al-Mahmood S, Courtois Y, Labarre J. 1999. In vivo involvement of heparan sulfate proteoglycan in the bioavailability, internalization, and catabolism of exogenous basic fibroblast growth factor. Mol Pharmacol 55:74-82.
24. Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson CP, Jr. 2001. Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293:1663-1666.
25. Esko JD, Zhang L. 1996. Influence of core protein sequence on glycosaminoglycan assembly. Curr Opin Struct Biol 6:663-670.
26. Fisher MC, Li Y, Seghatoleslami MR, Dealy CN, Kosher RA. 2006. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol 25:27-39.
27. Fitzgerald M, Hayward IP, Thomas AC, Campbell GR, Campbell JH. 1999. Matrix metalloproteinase can facilitate the heparanase-induced promotion of phenotype change in vascular smooth muscle cells. Atherosclerosis 145:97-106.
28. Fuchs E, Tumbar T, Guasch G. 2004. Socializing with the neighbors: Stem cells and their niche. Cell 116:769-778.
29. Gage FH, Ray J, Fisher LJ. 1995. Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci 18:159-192.
30. Gallagher JT, Turnbull JE. 1992. Heparan sulphate in the binding and activation of basic fibroblast growth factor. Glycobiology 2:523-528.
31. Grisaru S, Cano-Gauci D, Tee J, Filmus J, Rosenblum ND. 2001. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis. Dev Biol 231:31-46.
32. Guimond SE, Turnbull JE. 1999. Fibroblast growth factor receptor signaling is dictated by specific heparan sulphate saccharides. Curr Biol 9:1343-1346.
33. Gupta P, McCarthy JB, Verfaillie CM. 1996. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood 87:3229-3236.
34. Gustafsson E, Aszodi A, Ortega N, Hunziker EB, Denker HW, Werb Z, Fassler R. 2003. Role of collagen type II and perlecan in skeletal development. Ann N Y Acad Sci 995:140-150.
35. Han ZC, Bellucci S, Shen ZX, Maffrand JP, Pascal M, Petitou M, Lormeau J, Caen JP. 1996. Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators. J Cell Physiol 168:97-104.
36. Hecht JT, Hayes E, Haynes R, Cole WG, Long RJ, Farach-Carson MC, Carson DD. 2005. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes. Differentiation 73:212-221.
37. Hogg RC, Chipperfield H, Whyte KA, Stafford MR, Hansen MA, Cool SM, Nurcombe V, Adams DJ. 2004. Functional maturation of isolated neural progenitor cells from the adult rat hippocampus. Eur J Neurosci 19:2410-2420.
38. Hopker VH, Shewan D, Tessier-Lavigne M, Poo M, Holt C. 1999. Growth-cone attraction to netrin-1 is converted to repulsion by laminin-1. Nature 401:69-73.
39. Irie A, Yates EA, Turnbull JE, Holt CE. 2002. Specific heparan sulfate structures involved in retinal axon targeting. Development 129:61-70.
40. Irie A, Habuchi H, Kimata K, Sanai Y. 2003. Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem Biophys Res Commun 308:858-865.
41. Jackson SM, Nakato H, Sugiura M, Jannuzi A, Oakes R, Kaluza V, Golden C, Selleck SB. 1997. dally, a Drosophila glypican, controls cellular responses to the TGF-beta-related morphogen, Dpp. Development 124:4113-4120.
42. Joseph SJ, Ford MD, Barth C, Portbury S, Bartlett PF, Nurcombe V, Greferath U. 1996. A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant. Development 122:3443-3452.
43. Joyce JA, Freeman C, Meyer-Morse N, Parish CR, Hanahan D. 2005. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene 24:4037-4051.
44. Kan M, Wang F, Xu J, Crabb JW, Hou J, McKeehan WL. 1993. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259:1918-1921.
45. Kinsella MG, Irvin C, Reidy MA, Wight TN. 2004. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries. Atherosclerosis 175:51-57.
46. Klaassen CD, Boles JW. 1997. Sulfation and sulfotransferases 5: The importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. Faseb J 11:404-418.
47. Koziel L, Kunath M, Kelly OG, Vortkamp A. 2004. Ext1-dependent heparan sulfate regulates the range of Ihh signaling during endochondral ossification. Dev Cell 6:801-813.
48. Kreuger J, Prydz K, Pettersson RF, Lindahl U, Salmivirta M. 1999. Characterization of fibroblast growth factor 1 binding heparan sulfate domain. Glycobiology 9:723-729.
49. Krufka A, Guimond S, Rapraeger AC. 1996. Two hierarchies of FGF-2 signaling in heparin: Mitogenic stimulation and high-affinity binding/receptor transphosphorylation. Biochemistry 35:11131-11141.
50. Lander AD. 1998. Proteoglycans: Master regulators of molecular encounter? Matrix Biol 17:465-472.
51. Lin X, Perrimon N. 1999. Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signaling. Nature 400:281-284.
52. Lortat-Jacob H, Turnbull JE, Grimaud JA. 1995. Molecular organization of the interferon gamma-binding domain in heparan sulphate. Biochem J 310(Pt 2):497-505.
53. Luikart SD, Maniglia CA, Furcht LT, McCarthy JB, Oegema TR, Jr. 1990. A heparan sulfate-containing fraction of bone marrow stroma induces maturation of HL-60 cells in vitro. Cancer Res 50:3781-3785.
54. Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT. 1994. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J Biol Chem 269:11216-11223.
55. Maciag T, Friesel RE. 1995. Molecular mechanisms of fibroblast growth factor-1 traffick, signaling and release. Thromb Haemost 74:411-414.
56. Marie P, Debiais F, Cohen-Solal M, de Vernejoul MC. 2000. New factors controlling bone remodeling. Joint Bone Spine 67:150-156.
57. Martin GR, Timpl R, Kühn K. 1988. Basement membrane proteins: Molecular structure and function. Adv Protein Chem 39:1-50.
58. McKeehan WL, Kan M. 1994. Heparan sulfate fibroblast growth factor receptor complex: Structure-function relationships. Mol Reprod Dev 39:69-81; discussion 81-82.
59. McKeehan WL, Wang F, Kan M. 1998. The heparan sulfate-fibroblast growth factor family: Diversity of structure and function. Prog Nucleic Acid Res Mol Biol 59:135-176.
60. Merry CL, Wilson VA. 2002. Role of heparan sulfate-2-O-sulfotransferase in the mouse. Biochim Biophys Acta 1573:319-327.
61. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. 2000. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779-1782.
62. Nakato H, Kimata K. 2002. Heparan sulfate fine structure and specificity of proteoglycan functions. Biochim Biophys Acta 1573:312-318.
63. Naski MC, Ornitz DM. 1998. FGF signaling in skeletal development [In Process Citation]. Front Biosci 3:D781-D794.
64. Netelenbos T, Zuijderduijn S, Van Den Born J, Kessler FL, Zweegman S, Huijgens PC, Drager AM. 2002. Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J Leukoc Biol 72:353-362.
65. Nurcombe V, Ford MD, Wildschut JA, Bartlett PF. 1993. Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260:103-106.
66. Nurcombe V, Smart CE, Chipperfield H, Cool SM, Boilly B, Hondermarck H. 2000. The proliferative and migratory activities of breast cancer cells can be differentially regulated by heparan sulfates. J Biol Chem 275:30009-30018.
67. Ohkawara B, Iemura S, ten Dijke P, Ueno N. 2002. Action range of BMP is defined by its N-terminal basic amino acid core. Curr Biol 12:205-209.
68. Ornitz DM. 2000. FGFs, heparan sulfate and FGFRs: Complex interactions essential for development. Bioessays 22:108-112.
69. Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1465.
70. Paine-Saunders S, Viviano BL, Zupicich J, Skarnes WC, Saunders S. 2000. Glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Dev Biol 225:179-187.
71. Paine-Saunders S, Viviano BL, Economides AN, Saunders S. 2002. Heparan sulfate proteoglycans retain Noggin at the cell surface: A potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem 277:2089-2096.
72. Palmer TD, Markakis EA, Willhoite AR, Safar F, Gage FH. 1999. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci 19:8487-8497.
73. Parati EA, Pozzi S, Ottolina A, Onofrj M, Bez A, Pagano SF. 2004. Neural stem cells: An overview. J Endocrinol Invest 27:64-67.
74. Perrimon N, Bernfield M. 2000. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404:725-728.
75. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. 1999. Bone marrow as a potential source of hepatic oval cells. Science 284:1168-1170.
76. Princivalle M, de Agostini A. 2002. Developmental roles of heparan sulfate proteoglycans: A comparative review in Drosophila, mouse and human. Int J Dev Biol 46:267-278.
77. Prydz K, Dalen KT. 2000. Synthesis and sorting of proteoglycans. J Cell Sci 113 (Pt 2):193-205.
78. Pye DA, Vives RR, Hyde P, Gallagher JT. 2000. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: Differential requirements for the modulation of FGF-1 and FGF-2. Glycobiology 10:1183-1192.
79. Qian X, Goderie SK, Shen Q, Stern JH, Temple S. 1998. Intrinsic programs of patterned cell lineages in isolated vertebrate CNS ventricular zone cells. Development 125:3143-3152.
80. Raper JA. 2000. Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 10:88-94.
81. Rapraeger AC. 1995. In the clutches of proteoglycans: How does heparan sulfate regulate FGF binding? Chem Biol 2:645-649.
82. Rapraeger AC, Krufka A, Olwin BB. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708.
83. Ruoslahti E, Yamaguchi Y. 1991. Proteoglycans as modulators of growth factor activities. Cell 64:867-869.
84. Safaiyan F, Kolset SO, Prydz K, Gottfridsson E, Lindahl U, Salmivirta M. 1999. Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem 274:36267-36273.
85. Sampath TK, Coughlin JE, Whetstone RM, Banach D, Corbett C, Ridge RJ, Ozkaynak E, Oppermann H, Rueger DC. 1990. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem 265:13198-13205.
86. San Antonio JD, Lander AD, Karnovsky MJ, Slayter HS. 1994. Mapping the heparin-binding sites on type I collagen monomers and fibrils. J Cell Biol 125:1179-1188.
87. Sanderson RD, Turnbull JE, Gallagher JT, Lander AD. 1994. Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. J Biol Chem 269:13100-13106.
88. Serafini T, Kennedy TE, Galko MJ, Mirzayan C, Jessell TM, Tessier-Lavigne M. 1994. The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 78:409-424.
89. Shimo T, Gentili C, Iwamoto M, Wu C, Koyama E, Pacifici M. 2004. Indian Hedgehog and syndecans-3 coregulate chondrocyte proliferation and function during chick limb skeletogenesis. Dev Dyn 229:607-617.
90. Siczkowski M, Clarke D, Gordon MY. 1992. Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan sulfate. Blood 80:912-919.
91. Song HH, Shi W, Xiang YY, Filmus J. 2005. The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem 280:2116-2125.
92. Stringer SE, Forster MJ, Mulloy B, Bishop CR, Graham GJ, Gallagher JT. 2002. Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha. Blood 100:1543-1550.
93. Stringer SE, Nelson MS, Gupta P. 2003. Identification of an MIP-1alpha-binding heparan sulfate oligosaccharide that supports long-term in vitro maintenance of human LTC-ICs. Blood 101:2243-2245.
94. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. 1989. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563-1570.
95. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE. 1991. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 78:666-672.
96. Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A, Kamijo R. 2003. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 278:43229-43235.
97. Tessier-Lavigne M, Goodman CS. 1996. The molecular biology of axon guidance. Science 274:1123-1133.
98. Turnbull JE, Gallagher JT. 1993. Heparan sulphate: Functional role as a modulator of fibroblast growth factor activity. Biochem Soc Trans 21:477-482.
99. Verfaillie CM. 1992. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 79:2821-2826.
100. Verfaillie CM. 1993. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 82:2045-2053.
101. Vescovi AL, Galli R, Gritti A. 2001. The neural stem cells and their transdifferentiation capacity. Biomed Pharmacother 55:201-205.
102. Viviano BL, Silverstein L, Pflederer C, Paine-Saunders S, Mills K, Saunders S. 2005. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification. Dev Biol 282:152-162.
103. Walz A, McFarlane S, Brickman YG, Nurcombe V, Bartlett PF, Holt CE. 1997. Essential role of heparan sulfates in axon navigation and targeting in the developing visual system. Development 124:2421-2430.
104. Wang B, Zhang N, Qian KX, Geng JG. 2005. Conserved molecular players for axon guidance and angiogenesis. Curr Protein Pept Sci 6:473-478.
105. Wilkinson DG. 2001. Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci 2:155-164.
106. Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. 2005. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods 2:185-190.
107. Yabe T, Hata T, He J, Maeda N. 2005. Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. Glycobiology 15:982-993.
108. Yanagishita M, Hascall VC. 1992. Cell surface heparan sulfate proteoglycans. J Biol Chem 267:9451-9454.
109. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848.
110. Zweegman S, Van Den Born J, Mus AM, Kessler FL, Janssen JJ, Netelenbos T, Huijgens PC, Drager AM. 2004. Bone marrow stromal proteoglycans regulate megakaryocytic differentiation of human progenitor cells. Exp Cell Res 299:383-392.